دانلود کتاب پیشرفت‌ها در دیابت بالینی، چاقی و بیماری‌های متابولیک

Diabetes, obesity, and metabolic diseases have emerged as some of the most pressing global health challenges of our time. Their rising prevalence not only burdens individuals and families but also exerts profound pressure on healthcare systems worldwide. These conditions are intricately linked, often overlapping in pathophysiology and complicating clinical management. In recent years, we have witnessed remarkable breakthroughs in both pharmacological therapies and digital technologies. Novel agents such as weekly insulin, dual and triple incretin receptor agonists, and oral GLP-1 receptor agonists are transforming glycemic control and weight management. At the same time, the integration of digital tools—including AI-assisted monitoring, wearable devices, and telehealth platforms—has begun to redefine the way we deliver care. Yet, despite these promising advances, many critical questions remain. How effective are these treatments in real-world settings? How can technology be best utilized to personalize therapy and improve long-term outcomes? And how do we ensure equitable access to these innovations across diverse global populations? This Special Issue, entitled ”Advances in Clinical Diabetes, Obesity, and Metabolic Diseases”, brings together cutting-edge research, clinical insights, and real-world experiences from experts around the world. It aims to provide a comprehensive snapshot of where we stand and where we are heading in the fight against these complex diseases. We are deeply grateful to the authors and reviewers whose invaluable contributions have made this collection possible. It is our hope that the studies presented here will inspire continued dialogue, collaboration, and innovation in this ever-evolving field. We now invite you to explore the following Editorial, which offers a comprehensive overview of the significant findings and ongoing challenges highlighted in this Special Issue.